117 related articles for article (PubMed ID: 24725126)
21. Metastatic breast cancer with liver metastases: a registry analysis of clinicopathologic, management and outcome characteristics of 500 women.
Pentheroudakis G; Fountzilas G; Bafaloukos D; Koutsoukou V; Pectasides D; Skarlos D; Samantas E; Kalofonos HP; Gogas H; Pavlidis N
Breast Cancer Res Treat; 2006 Jun; 97(3):237-44. PubMed ID: 16322882
[TBL] [Abstract][Full Text] [Related]
22. Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicin-cyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial.
von Minckwitz G; Kümmel S; Vogel P; Hanusch C; Eidtmann H; Hilfrich J; Gerber B; Huober J; Costa SD; Jackisch C; Loibl S; Mehta K; Kaufmann M;
J Natl Cancer Inst; 2008 Apr; 100(8):542-51. PubMed ID: 18398097
[TBL] [Abstract][Full Text] [Related]
23. [Current trends in pharmacotherapy of breast cancer].
Boér K
Orv Hetil; 2002 Apr; 143(14):725-30. PubMed ID: 11975393
[TBL] [Abstract][Full Text] [Related]
24. Network pharmacology-based and clinically relevant prediction of the active ingredients and potential targets of Chinese herbs in metastatic breast cancer patients.
Mao Y; Hao J; Jin ZQ; Niu YY; Yang X; Liu D; Cao R; Wu XZ
Oncotarget; 2017 Apr; 8(16):27007-27021. PubMed ID: 28212580
[TBL] [Abstract][Full Text] [Related]
25. Tandem autotransplantation for the treatment of metastatic breast cancer.
Broun ER; Sridhara R; Sledge GW; Loesch D; Kneebone PH; Hanna M; Hromas R; Cornetta K; Einhorn LH
J Clin Oncol; 1995 Aug; 13(8):2050-5. PubMed ID: 7636548
[TBL] [Abstract][Full Text] [Related]
26. Docetaxel: an update of its use in advanced breast cancer.
Figgitt DP; Wiseman LR
Drugs; 2000 Mar; 59(3):621-51. PubMed ID: 10776837
[TBL] [Abstract][Full Text] [Related]
27. [Clinical study of comparison of CAF regimen and TP regimen in treatment of advanced breast cancer].
Lin XG; Xie DR; Yao HR; Li ZH; Jiang ZM; Liu TH
Ai Zheng; 2003 Apr; 22(4):411-4. PubMed ID: 12704001
[TBL] [Abstract][Full Text] [Related]
28. Dofequidar fumarate (MS-209) in combination with cyclophosphamide, doxorubicin, and fluorouracil for patients with advanced or recurrent breast cancer.
Saeki T; Nomizu T; Toi M; Ito Y; Noguchi S; Kobayashi T; Asaga T; Minami H; Yamamoto N; Aogi K; Ikeda T; Ohashi Y; Sato W; Tsuruo T
J Clin Oncol; 2007 Feb; 25(4):411-7. PubMed ID: 17179098
[TBL] [Abstract][Full Text] [Related]
29. Paclitaxel combined with weekly high-dose 5-fluorouracil/folinic acid and cisplatin in the treatment of advanced breast cancer.
Klaassen U; Wilke H; Seeber S
Semin Oncol; 1996 Oct; 23(5 Suppl 11):32-7. PubMed ID: 8893897
[TBL] [Abstract][Full Text] [Related]
30. Patterns of failure of complete responders following high-dose chemotherapy and autologous bone marrow transplantation for metastatic breast cancer: implications for the use of adjuvant radiation therapy.
Mundt AJ; Sibley GS; Williams S; Rubin SJ; Heimann R; Halpern H; Weichselbaum RR
Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):151-60. PubMed ID: 8083108
[TBL] [Abstract][Full Text] [Related]
31. [Safety and effectiveness of large dose compound Sophora flavescens Ait injection in the treatment of advanced malignant tumors].
Li DR; Lin HS
Zhonghua Zhong Liu Za Zhi; 2011 Apr; 33(4):291-4. PubMed ID: 21575502
[TBL] [Abstract][Full Text] [Related]
32. [Hungarian experience with docetaxel combination (TAC) in the adjuvant treatment of breast cancer. Results of BCIRG 001 randomized, multicentric, phase III trial].
Boér K; Láng I; Juhos E; Pintér T; Szántó J
Magy Onkol; 2003; 47(2):141-8. PubMed ID: 12975660
[TBL] [Abstract][Full Text] [Related]
33. Bendamustine prolongs progression-free survival in metastatic breast cancer (MBC): a phase III prospective, randomized, multicenter trial of bendamustine hydrochloride, methotrexate and 5-fluorouracil (BMF) versus cyclophosphamide, methotrexate and 5-fluorouracil (CMF) as first-line treatment of MBC.
von Minckwitz G; Chernozemsky I; Sirakova L; Chilingirov P; Souchon R; Marschner N; Kleeberg U; Tsekov C; Fritze D; Thomssen C; Stuart N; Vermorken JB; Loibl S; Merkle Kh; Kaufmann M
Anticancer Drugs; 2005 Sep; 16(8):871-7. PubMed ID: 16096436
[TBL] [Abstract][Full Text] [Related]
34. erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer.
Thor AD; Berry DA; Budman DR; Muss HB; Kute T; Henderson IC; Barcos M; Cirrincione C; Edgerton S; Allred C; Norton L; Liu ET
J Natl Cancer Inst; 1998 Sep; 90(18):1346-60. PubMed ID: 9747866
[TBL] [Abstract][Full Text] [Related]
35. LONG-TERM RESULTS OF COMBINATION THERAPY FOR LOCALLY ADVANCED BREAST CANCER.
Zhumakayeva A; Rakhimov K; Sirota V; Arystan L; Madiyarov A; Adekenov S
Georgian Med News; 2018 Sep; (282):30-35. PubMed ID: 30358536
[TBL] [Abstract][Full Text] [Related]
36. [Metastatic breast cancer: what are the objectives?].
Salvini P; Ripa C; Ginanni V
Tumori; 2000; 86(5 Suppl 1):S22-8. PubMed ID: 11195289
[TBL] [Abstract][Full Text] [Related]
37. A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancer.
Smalley RV; Lefante J; Bartolucci A; Carpenter J; Vogel C; Krauss S
Breast Cancer Res Treat; 1983; 3(2):209-20. PubMed ID: 6688538
[TBL] [Abstract][Full Text] [Related]
38. Long-term results of combined-modality therapy for locally advanced breast cancer with ipsilateral supraclavicular metastases: The University of Texas M.D. Anderson Cancer Center experience.
Brito RA; Valero V; Buzdar AU; Booser DJ; Ames F; Strom E; Ross M; Theriault RL; Frye D; Kau SW; Asmar L; McNeese M; Singletary SE; Hortobagyi GN
J Clin Oncol; 2001 Feb; 19(3):628-33. PubMed ID: 11157012
[TBL] [Abstract][Full Text] [Related]
39. A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.
Pietri E; Andreis D; Fabbri F; Menna C; Schirone A; Kopf B; Rocca A; Amadori D; De Giorgi U
Oncologist; 2015 Mar; 20(3):239-40. PubMed ID: 25637379
[TBL] [Abstract][Full Text] [Related]
40. [A case of recurrent breast cancer successfully treated with docetaxel].
Koshizuka K; Hada M; Muto S; Hagiwara J; Nakagomi H; Takano K; Kamiya K; Tada Y
Gan To Kagaku Ryoho; 1999 Sep; 26(10):1479-81. PubMed ID: 10500538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
